Thiotepa Fresenius Kabi 100 mg inj. sol. (pwdr., conc.) i.v. vial
Country: Belgium
Language: English
Source: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
Thiotepa 100 mg
Available from:
Fresenius Kabi SA-NV
ATC code:
L01AC01
Pharmaceutical form:
Powder for concentrate for solution for infusion
Administration route:
Intravenous use
Therapeutic area:
Thiotepa
Product summary:
CTI Extended: 661839-01
Authorization status:
Commercialised: No
Authorization date:
2023-10-02
